Report : Europe Histopathology Services Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type of Examination (Surgical Specimen, Breast Biopsy, Lung Biopsy, Renal Biopsy, Gastrointestinal Biopsy, Pancreatic Biopsy, Skin Tissue Biopsy, Testicular Biopsy, and Others) and End User (Diagnostic Laboratories & Reference Laboratories, Research Institutes, and Others)
The surgical specimen segment by type of examination is estimated to lead the market growth during the forecast period.
According to a new market research study of “Europe Histopathology Services Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type of Examination, End User and Country.” The Europe histopathology services market is expected to reach US$ 10,327.65 million by 2028 from US$ 7,202.97 million in 2021; it is estimated to grow at a CAGR of 5.3% from 2021 to 2028. The report highlights trends prevailing in the Europe histopathology services market and the factors driving market along with those that act as hindrances.
Chronic diseases, such as cardiovascular disorders, neurological disorders, autoimmune disorders, and cancer, are the leading causes of death and disabilities worldwide. Rapid change in lifestyle, and surge in the consumption of alcohol and tobacco products are among the prominent factors triggering the incidence of cancer among populations. Autoimmune diseases further contribute to disorders among a significant number of people. However, increasing research activities to develop effective treatments for these diseases are boosting the Europe histopathology services market growth. Researchers and therapists exploring therapies for these diseases conduct detailed histopathological analyses to understand the disease mechanisms, which assist in the designing of therapies for their management. Thus, the rising number of chronic diseases worldwide are fueling the histopathological services market growth. Further, technological developments are allowing medical professionals to upgrade their existing diagnostic procedures and protocols. Innovations in instrumentation, visualization tools, and invasion techniques are bringing improvements and greater accuracy in diseases diagnoses. Further, strategic alliances between leading and emerging market players to support the promising studies for advanced histopathological analyses are likely to serve significant future trends in the market. For instance, Telemedicine Clinic (A Unilabs Company), in partnership with Alliance Medical and Doncaster Clinical Commissioning Group (CCG), started providing reporting services for low-dose CT scans, as a part of the Targeted National Lung Health Check program of the National Health Services (NHS), UK.
Europe is facing the massive impact of an outbreak due to exponential growth of infections of COVID-19 in the region. In the last few months, the number of patient visits to hospitals has reduced significantly, despite emergency and OPD services being available in hospitals. Hence, due to the lockdown in many countries, elective and cancer surgeries have reduced significantly. Moreover, due to the robust increase in the incidence of COVID- 19, pathology laboratories are now prioritizing and focusing on COVID-19 tests. The rapid increase in the number of infected patients in the UK and Germany is likely to hamper the growth of Europe histopathology services market and result in slowing down the market growth in the near future.
The Europe histopathology services market, by type of examination, is segmented into surgical specimen, breast biopsy, lung biopsy, renal biopsy, gastrointestinal biopsy, pancreatic biopsy, skin tissue biopsy, testicular biopsy, and others. Based on end user, the Europe histopathology services market is segmented into diagnostic laboratories and reference laboratories, research institutes, and others. Geographically, the Europe histopathology services market can be sub-segmented into UK, Germany, France, Italy, Spain and Rest of Europe.
Acculabs Diagnostics UK Ltd, Laboratory Corporation of America Holdings, TPL Path Labs, UNILABS, Cellular Pathology Services, Targos, Cureline Global Translational CRO and CHARLES RIVER LABORATORIES, INC. are among the leading companies operating in the Europe histopathology services market.
Contact Person: Sameer Joshi
Email Id: email@example.com